Management of Hyponatremia (Na ≈ 120 mmol/L) in Patients on Thiazide Diuretics

Immediate Management of Severely Symptomatic Hyponatremia

In patients presenting with seizures, coma, or marked altered mental status, administer 3 % hypertonic saline as a 100–150 mL IV bolus over 10–20 minutes. [1][2]
Aim for an initial rise of 4–6 mEq/L in serum sodium within the first 1–2 hours (or until severe symptoms resolve). [1][2]
Do not exceed a total correction of 8–10 mEq/L in the first 24 hours to avoid osmotic demyelination syndrome (ODS). [1][2]
Re‑measure serum sodium every 2 hours during the hypertonic‑saline phase. [1][2]

The recommended overall correction goal is 4–6 mEq/L increase over the first 24 hours. [1][2]
The maximum safe limit remains 8–10 mEq/L in any 24‑hour period. [1][2]
For chronic hyponatremia (>48 h duration), a slower correction trajectory is advised to further reduce ODS risk. 2

Physical examination alone identifies true volume status with only ≈ 41 % sensitivity; adjunct laboratory testing is essential. [3][4]
Urine sodium < 30 mEq/L indicates volume depletion and predicts responsiveness to isotonic saline. [3][4]
Serum uric acid < 4 mg/dL may point toward SIADH rather than true volume depletion. [3][4]
In hypovolemic, thiazide‑induced hyponatremia, initiate volume repletion with 0.9 % NaCl (normal saline), titrated to clinical response. [1][3]4
Monitor serum sodium every 4–6 hours while using isotonic saline. [1][2]
If the patient appears euvolemic (suggesting a SIADH component), impose fluid restriction of 500–1000 mL/day and adjust based on sodium trends. [1][5]

Hypertonic‑saline regimen: serum sodium checks every 2 hours. [1][2]
Isotonic‑saline regimen: serum sodium checks every 4–6 hours. [1][2]
Perform daily weights and strict intake/output recording throughout correction. [1][2]

Recognize that an overcorrection (> 10 mEq/L in 24 hours) can precipitate ODS; if it occurs, consider desmopressin plus hypotonic fluids to safely re‑lower serum sodium. 2

Transition the patient to non‑thiazide antihypertensive therapy (e.g., ACE inhibitor, ARB, or calcium‑channel blocker) to prevent recurrence. 6
Continue weekly serum sodium monitoring for the first month, then monthly thereafter.

All facts are derived from peer‑reviewed sources identified by citation IDs; strength of evidence was not explicitly graded in the source material.